NYSE: CLS
CELESTICA INCCIK 0001030894 · SIC 3672 · Printed Circuit Boards
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (MAN 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade CLS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Celestica raises $3.39B through 11.1M share offering at $310/share for capex and working capital
3 material changes detected. Sign up free to read the summary.
Celestica prices $3.0B follow-on offering of common shares at NYSE reference price of $107.05
5 material changes detected. Sign up free to read the summary.
Celestica Inc. files prospectus supplement for offering of common shares; terms not yet disclosed
7 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Oct 26, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(in millions of U.S. dollars, except per share amounts)
| Description | Three months ended September 30 2026 | Three months ended September 30 2025 | Nine months ended September 30 2026 | Nine months ended September 30 2025 |
|---|---|---|---|---|
| Revenue | 5,829.7 | 3,194.0 | 14,575.3 | 8,736.0 |
| Cost of sales | 5,188.9 | 2,777.9 | 12,919.8 | 7,675.0 |
| Gross profit | 640.8 | 416.1 | 1,655.5 | 1,061.0 |
| Selling, general and administrative expenses | 118.2 | 38.4 | 293.7 | 189.8 |
| Research and development | 51.2 | 36.4 | 138.7 | 88.0 |
| Amortization of intangible assets | 10.5 | 11.4 | 33.3 | 33.6 |
| Restructuring and other charges (recoveries) | 0.9 | 4.9 | (0.6) | 23.3 |
| Earnings from operations | 460.0 | 325.0 | 1,190.4 | 726.3 |
| Finance costs | 24.1 | 13.8 | 63.3 | 43.2 |
| Interest income | (19.7) | (1.0) | (25.5) | (3.2) |
| Miscellaneous expense (income) | (0.2) | 1.3 | (1.1) | 4.4 |
| Earnings before income taxes | 455.8 | 310.9 | 1,153.7 | 681.9 |
| Income tax expense (recovery) | 14 | |||
| Current | 84.8 | 44.2 | 250.2 | 133.0 |
| Deferred | (26.2) | (1.1) | (74.8) | (16.1) |
| 58.6 | 43.1 | 175.4 | 116.9 | |
| Net earnings | 397.2 | 267.8 | 978.3 | 565.0 |
| Earnings per share: | ||||
| Basic | 3.30 | 2.33 | 8.38 | 4.90 |
| Diluted | 3.26 | 2.31 | 8.30 | 4.86 |
| Weighted-average shares used in computing per share amounts (in millions): | ||||
| Basic | 120.5 | 115.0 | 116.8 | 115.4 |
| Diluted | 121.8 | 115.9 | 117.9 | 116.2 |
Condensed Consolidated Balance Sheets (Unaudited)
(in millions of U.S. dollars)
| Description | September 30 2026 | December 31 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 3,961.3 | 595.6 |
| Accounts receivable, net | 3,763.1 | 2,638.1 |
| Inventories | 4,509.7 | 2,188.0 |
| Other current assets | 309.6 | 251.5 |
| Total current assets | 12,543.7 | 5,673.2 |
| Property, plant and equipment, net | 1,403.3 | 586.0 |
| Operating lease right-of-use assets | 194.7 | 124.1 |
| Goodwill | 333.3 | 333.1 |
| Intangible assets, net | 234.2 | 266.2 |
| Deferred income taxes | 232.5 | 156.4 |
| Other non-current assets | 196.8 | 74.1 |
| Total assets | 15,138.5 | 7,213.1 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Current portion of borrowings under credit facility and finance lease obligations | 27.3 | 26.0 |
| Accounts payable | 5,040.6 | 1,866.1 |
| Accrued and other current liabilities and provisions | 2,559.1 | 1,896.8 |
| Income taxes payable | 142.8 | 150.7 |
| Total current liabilities | 7,769.8 | 3,939.6 |
| Long-term portion of borrowings under credit facility and finance lease obligations | 791.5 | 750.5 |
| Pension and non-pension post-employment benefit obligations | 90.8 | 89.5 |
| Other non-current liabilities and provisions | 232.5 | 176.0 |
| Deferred income taxes | 39.9 | 41.2 |
| Total liabilities | 8,924.5 | 4,996.8 |
| Equity: | ||
| Total equity | 6,214.0 | 2,216.3 |
| Total liabilities and equity | 15,138.5 | 7,213.1 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in millions of U.S. dollars)
| Description | Three months ended September 30 2026 | Three months ended September 30 2025 | Nine months ended September 30 2026 | Nine months ended September 30 2025 |
|---|---|---|---|---|
| Cash provided by (used in): | 2026 | 2025 | 2026 | 2025 |
| Operating activities: | ||||
| Net earnings | 397.2 | 267.8 | 978.3 | 565.0 |
| Adjustments to reconcile net earnings to net cash flows provided by operating activities: | ||||
| Depreciation and amortization | 48.5 | 40.3 | 132.1 | 123.0 |
| SBC | 21.3 | 15.6 | 71.1 | 56.8 |
| Total return swap (TRS) fair value adjustments | 3.9 | (113.3) | (83.2) | (191.6) |
| Restructuring and other charges (recoveries) | — | 2.5 | (10.0) | 2.9 |
| Unrealized losses on hedge derivatives | — | 1.1 | — | 3.7 |
| Deferred income taxes | (26.2) | (1.1) | (74.8) | (16.1) |
| Other | 7.0 | 5.7 | 9.8 | 24.1 |
| Changes in non-cash working capital items: | ||||
| Accounts receivable | (424.9) | (151.5) | (1,125.0) | (370.3) |
| Inventories | (1,108.0) | (128.6) | (2,321.7) | (286.1) |
| Other current assets | (22.9) | (0.9) | (10.2) | (7.3) |
| Accounts payable, accrued and other current liabilities, provisions and income taxes payable | 1,493.8 | 188.6 | 3,590.5 | 504.8 |
| Net cash provided by operating activities | 389.7 | 126.2 | 1,156.9 | 408.9 |
| Investing activities: | ||||
| Purchase of property, plant and equipment | (274.1) | (37.3) | (767.4) | (106.5) |
| Proceeds from sale of assets | 11.9 | — | 23.0 | — |
| Other | — | — | (2.5) | (2.5) |
| Net cash used in investing activities | (262.2) | (37.3) | (746.9) | (109.0) |
| Financing activities: | ||||
| Borrowings under revolving loans | 210.0 | — | 810.0 | 500.0 |
| Repayments under revolving loans | (210.0) | (90.0) | (810.0) | (500.0) |
| Borrowings under term loans | — | — | 250.0 | — |
| Repayments under term loans | (4.4) | (4.4) | (238.1) | (13.1) |
| Principal payments of finance leases | (2.3) | (2.4) | (7.3) | (7.6) |
| Proceeds from issuance of capital stock under SBC plans | — | — | — | 0.3 |
| Proceeds from issuance of capital stock under public offering, net of issuance costs | 3,391.3 | — | 3,391.3 | — |
| Repurchase of capital stock for cancellation | — | — | (22.6) | (117.7) |
| Purchase of treasury stock for SBC plans | (37.6) | — | (37.6) | (221.6) |
| Proceeds from TRS settlement | — | — | — | 98.6 |
| SBC cash settlement | (47.3) | — | (373.6) | (156.0) |
| Debt issuance costs paid | (1.6) | — | (6.4) | (0.2) |
| Net cash provided by (used in) financing activities | 3,298.1 | (96.8) | 2,955.7 | (417.3) |
| Net increase (decrease) in cash and cash equivalents | 3,425.6 | (7.9) | 3,365.7 | (117.4) |
| Cash and cash equivalents, beginning of period | 535.7 | 313.8 | 595.6 | 423.3 |
| Cash and cash equivalents, end of period | 3,961.3 | 305.9 | 3,961.3 | 305.9 |
| Supplemental disclosure information: | ||||
| Interest paid | 17.9 | 13.4 | 57.2 | 40.7 |
| Net income taxes paid | 138.9 | 45.7 | 284.4 | 101.9 |
| Non-cash investing activity: | ||||
| Unpaid purchases of property, plant and equipment at end of period | 238.3 | 24.4 | 238.3 | 24.4 |
Amounts as printed on the EDGAR/iXBRL face — (in millions of U.S. dollars, except per share amounts); (in millions of U.S. dollars). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗